Redefined clinical features and diagnostic criteria in autoimmune polyendocrinopathycandidiasis- ectodermal dystrophy

JCI Insight

Volumn 1, Issue 13, 2021, Pages

  Ferre, Elise M N ^a   Rose, Stacey R ^a   Rosenzweig, Sergio D ^b   Burbelo, Peter D ^c   Romito, Kimberly R ^b   Niemela, Julie E ^b   Rosen, Lindsey B ^a   Break, Timothy J ^a   Gu, Wenjuan ^d   Hunsberger, Sally ^a   Browne, Sarah K ^a   Hsu, Amy P ^a   Rampertaap, Shakuntala ^b   Swamydas, Muthulekha ^a   Collar, Amanda L ^a   Kong, Heidi H ^e   Lee, Chyi Chia Richard ^e   Chascsa, David ^f   Simcox, Thomas ^f   Pham, Angela ^a   Bondici, Anamaria ^a   Natarajan, Mukil ^a   Monsale, Joseph ^b   Kleiner, David E ^e   Quezado, Martha ^e   Alevizos, Ilias ^g   Moutsopoulos, Niki M ^c   Yockey, Lynne ^a   Frein, Cathleen ^d   Soldatos, Ariane ^h   Calvo, Katherine R ^b   Adjemian, Jennifer ⁱ   Similuk, Morgan N ^a   Lang, David M ^b   Stone, Kelly D ^a   Uzel, Gulbu ^a   Kopp, Jeffrey B ^f   Bishop, Rachel J ^j   Holland, Steven M ^a   Olivier, Kenneth N ^k   Fleisher, Thomas A ^b   Heller, Theo ^f   Winer, Karen K ^l   Lionakis, Michail S ^a   more..

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^d FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

^f NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^g Sjögren's Syndrome and Salivary Gland Dysfunction Unit   (United States)

^h Office of the Director   (United States)

ⁱ Laboratory of Clinical Infectious Diseases   (United States)

^j NATIONAL EYE INSTITUTE   (United States)

^k NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^l EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADP RIBOSYL CYCLASE/CYCLIC ADP RIBOSE HYDROLASE 1; AUTOIMMUNE REGULATOR PROTEIN; COMPLEMENT COMPONENT C3D RECEPTOR; INTERFERON ANTIBODY; OMEGA INTERFERON ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AIRE GENE; AMERICAN; ARTICLE; AUTOIMMUNE POLYENDOCRINOPATHY CANDIDIASIS ECTODERMAL DYSTROPHY; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; ENAMEL HYPOPLASIA; ENTEROPATHY; FEMALE; GASTRITIS; GENE DELETION; GENE MUTATION; HEPATITIS; HETEROZYGOSITY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFANT; MALE; OBSERVATIONAL STUDY; PNEUMONIA; PROSPECTIVE STUDY; SJOEGREN SYNDROME; SKIN BIOPSY; URTICARIA;

EID: 85100040012     PISSN: None     EISSN: 23793708     Source Type: Journal    
DOI: 10.1172/jci.insight.88782     Document Type: Article

References (64)

1. Anderson MS, et al. Projection of an immunological self shadow within the thymus by the aire protein. Science. 2002;298(5597):1395-1401.
2. Mathis D, Benoist C. Aire. Annu Rev Immunol. 2009;27:287-312.
3. Oftedal BE, et al. Dominant mutations in the autoimmune regulator AIRE are associated with common organ-specific autoimmune diseases. Immunity. 2015;42(6):1185-1196.
4. Cetani F, et al. A novel mutation of the autoimmune regulator gene in an Italian kindred with autoimmune polyendocrinopathy- candidiasis-ectodermal dystrophy, acting in a dominant fashion and strongly cosegregating with hypothyroid autoimmune thyroiditis. J Clin Endocrinol Metab. 2001;86(10):4747-4752.
5. Su MA, et al. Mechanisms of an autoimmunity syndrome in mice caused by a dominant mutation in Aire. J Clin Invest. 2008;118(5):1712-1726.
6. Ahonen P, Myllärniemi S, Sipilä I, Perheentupa J. Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. N Engl J Med. 1990;322(26):1829-1836.
7. Perheentupa J. Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. J Clin Endocrinol Metab. 2006;91(8):2843-2850.
8. Wolff AS, et al. Autoimmune polyendocrine syndrome type 1 in Norway: phenotypic variation, autoantibodies, and novel mutations in the autoimmune regulator gene. J Clin Endocrinol Metab. 2007;92(2):595-603.
9. Husebye ES, Perheentupa J, Rautemaa R, Kämpe O. Clinical manifestations and management of patients with autoimmune polyendocrine syndrome type I. J Intern Med. 2009;265(5):514-529.
10. Dominguez M, et al. Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in the Irish population. J Pediatr Endocrinol Metab. 2006;19(11):1343-1352.
11. F Magitta N, et al. Autoimmune polyendocrine syndrome type I in Slovakia: relevance of screening patients with autoimmune Addison's disease. Eur J Endocrinol. 2008;158(5):705-709.
12. Meloni A, et al. Autoimmune polyendocrine syndrome type 1: an extensive longitudinal study in Sardinian patients. J Clin Endocrinol Metab. 2012;97(4):1114-1124.
13. Meager A, et al. Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1. PLoS Med. 2006;3(7):e289.
14. Zlotogora J, Shapiro MS. Polyglandular autoimmune syndrome type I among Iranian Jews. J Med Genet. 1992;29(11):824-826.
15. Orlova EM, et al. Autoimmune polyglandular syndrome type 1 in Russian patients: clinical variants and autoimmune regulator mutations. Horm Res Paediatr. 2010;73(6):449-457.
16. Pearce SH, et al. A common and recurrent 13-bp deletion in the autoimmune regulator gene in British kindreds with autoimmune polyendocrinopathy type 1. Am J Hum Genet. 1998;63(6):1675-1684.
17. Myhre AG, et al. Autoimmune polyendocrine syndrome type 1 (APS I) in Norway. Clin Endocrinol (Oxf). 2001;54(2):211-217.
18. Neufeld M, Maclaren NK, Blizzard RM. Two types of autoimmune Addison's disease associated with different polyglandular autoimmune (PGA) syndromes. Medicine (Baltimore). 1981;60(5):355-362.
19. Podkrajsek KT, Bratanic N, Krzisnik C, Battelino T. Autoimmune regulator-1 messenger ribonucleic acid analysis in a novel intronic mutation and two additional novel AIRE gene mutations in a cohort of autoimmune polyendocrinopathy-candidiasis- ectodermal dystrophy patients. J Clin Endocrinol Metab. 2005;90(8):4930-4935.
20. Stolarski B, et al. Molecular background of polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome in a Polish population: novel AIRE mutations and an estimate of disease prevalence. Clin Genet. 2006;70(4):348-354.
21. Valenzise M, et al. Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy: report of seven additional sicilian patients and overview of the overall series from sicily. Horm Res Paediatr. 2014;82(2):127-132.
22. Bruserud Ø, et al. A longitudinal follow-up of Autoimmune polyendocrine syndrome type 1 [published online ahead of print June 2, 2016]. J Clin Endocrinol Metab. doi:10.1210/jc.2016-1821.
23. Popler J, et al. Autoimmune polyendocrine syndrome type 1: Utility of KCNRG autoantibodies as a marker of active pulmonary disease and successful treatment with rituximab. Pediatr Pulmonol. 2012;47(1):84-87.
24. Huibregtse KE, Wolfgram P, Winer KK, Connor EL. Polyglandular autoimmune syndrome type I - a novel AIRE mutation in a North American patient. J Pediatr Endocrinol Metab. 2014;27(11-12):1257-1260.
25. Friedman TC, et al. Frequent occurrence of asplenism and cholelithiasis in patients with autoimmune polyglandular disease type I. Am J Med. 1991;91(6):625-630.
26. Bøe Wolff AS, et al. AIRE variations in Addison's disease and autoimmune polyendocrine syndromes (APS): partial gene deletions contribute to APS I. Genes Immun. 2008;9(2):130-136.
27. Heino M, et al. Mutation analyses of North American APS-1 patients. Hum Mutat. 1999;13(1):69-74.
28. Winqvist O, Gustafsson J, Rorsman F, Karlsson FA, Kämpe O. Two different cytochrome P450 enzymes are the adrenal antigens in autoimmune polyendocrine syndrome type I and Addison's disease. J Clin Invest. 1993;92(5):2377-2385.
29. Winqvist O, Karlsson FA, Kämpe O. 21-Hydroxylase, a major autoantigen in idiopathic Addison's disease. Lancet. 1992;339(8809):1559-1562.
30. Puel A, et al. Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I. J Exp Med. 2010;207(2):291-297.
31. Kisand K, et al. Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines. J Exp Med. 2010;207(2):299-308.
32. Ekwall O, et al. Identification of tryptophan hydroxylase as an intestinal autoantigen. Lancet. 1998;352(9124):279-283.
33. Shum AK, et al. BPIFB1 is a lung-specific autoantigen associated with interstitial lung disease. Sci Transl Med. 2013;5(206):206ra139.
34. Alimohammadi M, et al. Pulmonary autoimmunity as a feature of autoimmune polyendocrine syndrome type 1 and identification of KCNRG as a bronchial autoantigen. Proc Natl Acad Sci U S A. 2009;106(11):4396-4401.
35. Perniola R, Lobreglio G, Rosatelli MC, Pitotti E, Accogli E, De Rinaldis C. Immunophenotypic characterisation of peripheral blood lymphocytes in autoimmune polyglandular syndrome type 1: clinical study and review of the literature. J Pediatr Endocrinol Metab. 2005;18(2):155-164.
36. Sedivá A, Ciháková D, Lebl J. Immunological findings in patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) and their family members: are heterozygotes subclinically affected?. J Pediatr Endocrinol Metab. 2002;15(9):1491-1496.
37. Wolff AS, Oftedal BE, Kisand K, Ersvaer E, Lima K, Husebye ES. Flow cytometry study of blood cell subtypes reflects autoimmune and inflammatory processes in autoimmune polyendocrine syndrome type I. Scand J Immunol. 2010;71(6):459-467.
38. Isnardi I, et al. Complement receptor 2/CD21- human naive B cells contain mostly autoreactive unresponsive clones. Blood. 2010;115(24):5026-5036.
39. Wehr C, et al. The EUROclass trial: defining subgroups in common variable immunodeficiency. Blood. 2008;111(1):77-85.
40. Warnatz K, et al. Expansion of CD19(hi)CD21(lo/neg) B cells in common variable immunodeficiency (CVID) patients with autoimmune cytopenia. Immunobiology. 2002;206(5):502-513.
41. Kuehn HS, et al. Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4. Science. 2014;345(6204):1623-1627.
42. Wehr C, et al. A new CD21low B cell population in the peripheral blood of patients with SLE. Clin Immunol. 2004;113(2):161-171.
43. Rubtsov AV, Rubtsova K, Kappler JW, Jacobelli J, Friedman RS, Marrack P. CD11c-Expressing B Cells Are Located at the T Cell/B Cell Border in Spleen and Are Potent APCs. J Immunol. 2015;195(1):71-79.
44. Rubtsov AV, et al. Toll-like receptor 7 (TLR7)-driven accumulation of a novel CD11c+ B-cell population is important for the development of autoimmunity. Blood. 2011;118(5):1305-1315.
45. Hao Y, O'Neill P, Naradikian MS, Scholz JL, Cancro MP. A B-cell subset uniquely responsive to innate stimuli accumulates in aged mice. Blood. 2011;118(5):1294-1304.
46. Kisand K, Peterson P. Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy. J Clin Immunol. 2015;35(5):463-478.
47. Jääskeläinen J, Perheentupa J. Autoimmune polyendocrinopathy-candidosis-ectodermal dystrophy (APECED)-a diagnostic and therapeutic challenge. Pediatr Endocrinol Rev. 2009;7(2):15-28.
48. Vitali C, et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American- European Consensus Group. Ann Rheum Dis. 2002;61(6):554-558.
49. Pappas PG, et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;48(5):503-535.
50. Vulvovaginal Candidiasis. Center for Disease Control and Prevention. http://www.cdc.gov/std/tg2015/candidiasis.htm. Updated June 4, 2015. Accessed July 19, 2016.
51. Burbelo PD, Ching KH, Bush ER, Han BL, Iadarola MJ. Antibody-profiling technologies for studying humoral responses to infectious agents. Expert Rev Vaccines. 2010;9(6):567-578.
52. Burbelo PD, et al. A new luminescence assay for autoantibodies to mammalian cell-prepared insulinoma-associated protein 2. Diabetes Care. 2008;31(9):1824-1826.
53. Burbelo PD, et al. Extrapancreatic autoantibody profiles in type I diabetes. PLoS One. 2012;7(9):e45216.
54. Burbelo PD, et al. Anti-cytokine autoantibodies are associated with opportunistic infection in patients with thymic neoplasia. Blood. 2010;116(23):4848-4858.
55. Ching KH, et al. Two major autoantibody clusters in systemic lupus erythematosus. PLoS One. 2012;7(2):e32001.
56. Burbelo PD, et al. Rapid induction of autoantibodies during ARDS and septic shock. J Transl Med. 2010;8:97.
57. Burbelo PD, Goldman R, Mattson TL. A simplified immunoprecipitation method for quantitatively measuring antibody responses in clinical sera samples by using mammalian-produced Renilla luciferase-antigen fusion proteins. BMC Biotechnol. 2005;5:22.
58. Burbelo PD, Ching KH, Klimavicz CM, Iadarola MJ. Antibody profiling by Luciferase Immunoprecipitation Systems (LIPS). J Vis Exp. 2009;(32):1549.
59. Ding L, Mo A, Jutivorakool K, Pancholi M, Holland SM, Browne SK. Determination of human anticytokine autoantibody profiles using a particle-based approach. J Clin Immunol. 2012;32(2):238-245.
60. Kaczur V, et al. Effect of anti-thyroid peroxidase (TPO) antibodies on TPO activity measured by chemiluminescence assay. Clin Chem. 1997;43(8 Pt 1):1392-1396.
61. Walikonis JE, Lennon VA. Radioimmunoassay for glutamic acid decarboxylase (GAD65) autoantibodies as a diagnostic aid for stiff-man syndrome and a correlate of susceptibility to type 1 diabetes mellitus. Mayo Clin Proc. 1998;73(12):1161-1166.
62. Tanaka H, et al. Steroid 21-hydroxylase autoantibodies: measurements with a new immunoprecipitation assay. J Clin Endocrinol Metab. 1997;82(5):1440-1446.
63. Lionakis MS, Lim JK, Lee CC, Murphy PM. Organ-specific innate immune responses in a mouse model of invasive candidiasis. J Innate Immun. 2011;3(2):180-199.
64. R Core Team (2014). The R Project for Statistical Computing. http://www.R-project.org. Accessed July 19, 2016.